Breakthrough · August 4, 2026
FDA Grants Breakthrough Status to Lilly Drug for KRAS Pancreatic Cancer
A novel KRAS G12C inhibitor receives Breakthrough Therapy designation for previously treated advanced pancreatic cancer patients....